Medpace Holdings EPS - Earnings per Share 2014-2025 | MEDP
Medpace Holdings annual and quarterly earnings per share history from 2014 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Medpace Holdings EPS for the quarter ending September 30, 2025 was $3.86, a 28.24% increase year-over-year.
- Medpace Holdings EPS for the twelve months ending September 30, 2025 was $14.30, a 25.22% increase year-over-year.
- Medpace Holdings 2024 annual EPS was $12.63, a 42.23% increase from 2023.
- Medpace Holdings 2023 annual EPS was $8.88, a 21.98% increase from 2022.
- Medpace Holdings 2022 annual EPS was $7.28, a 51.35% increase from 2021.
| Medpace Holdings Annual EPS | |
|---|---|
| 2024 | $12.63 |
| 2023 | $8.88 |
| 2022 | $7.28 |
| 2021 | $4.81 |
| 2020 | $3.84 |
| 2019 | $2.67 |
| 2018 | $1.97 |
| 2017 | $0.98 |
| 2016 | $0.37 |
| 2015 | $-0.28 |
| 2014 | $-0.50 |
| 2013 | $0.95 |
| Medpace Holdings Quarterly EPS | |
|---|---|
| 2025-09-30 | $3.86 |
| 2025-06-30 | $3.10 |
| 2025-03-31 | $3.67 |
| 2024-12-31 | $3.67 |
| 2024-09-30 | $3.01 |
| 2024-06-30 | $2.75 |
| 2024-03-31 | $3.20 |
| 2023-12-31 | $2.46 |
| 2023-09-30 | $2.22 |
| 2023-06-30 | $1.93 |
| 2023-03-31 | $2.27 |
| 2022-12-31 | $2.08 |
| 2022-09-30 | $2.05 |
| 2022-06-30 | $1.46 |
| 2022-03-31 | $1.69 |
| 2021-12-31 | $1.32 |
| 2021-09-30 | $1.29 |
| 2021-06-30 | $1.06 |
| 2021-03-31 | $1.14 |
| 2020-12-31 | $1.35 |
| 2020-09-30 | $1.09 |
| 2020-06-30 | $0.64 |
| 2020-03-31 | $0.76 |
| 2019-12-31 | $0.80 |
| 2019-09-30 | $0.63 |
| 2019-06-30 | $0.73 |
| 2019-03-31 | $0.51 |
| 2018-12-31 | $0.60 |
| 2018-09-30 | $0.52 |
| 2018-06-30 | $0.45 |
| 2018-03-31 | $0.40 |
| 2017-12-31 | $0.30 |
| 2017-09-30 | $0.25 |
| 2017-06-30 | $0.23 |
| 2017-03-31 | $0.20 |
| 2016-12-31 | $-0.02 |
| 2016-09-30 | $0.13 |
| 2016-06-30 | $0.15 |
| 2016-03-31 | $0.11 |
| 2015-12-31 | $0.00 |
| 2015-09-30 | $0.00 |
| 2014-12-31 | $0.00 |
| 2013-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $16.568B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $157.813B | 28.64 |
| HCA Healthcare (HCA) | United States | $113.378B | 17.58 |
| CVS Health (CVS) | United States | $95.741B | 11.01 |
| Elevance Health (ELV) | United States | $75.968B | 11.33 |
| Cencora (COR) | United States | $70.528B | 22.74 |
| Natera (NTRA) | United States | $31.966B | 0.00 |
| Labcorp Holdings (LH) | United States | $22.407B | 17.08 |
| DiDi Global (DIDIY) | China | $22.168B | 20.48 |
| Viatris (VTRS) | United States | $15.756B | 5.87 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.545B | 0.00 |
| ICON (ICLR) | Ireland | $14.422B | 14.31 |
| Solventum (SOLV) | United States | $13.340B | 12.95 |
| BioMerieux (BMXMF) | France | $13.150B | 0.00 |
| CochLear (CHEOY) | Australia | $12.190B | 0.00 |
| Revvity (RVTY) | United States | $12.141B | 21.12 |
| Charles River Laboratories (CRL) | United States | $10.494B | 20.21 |
| Sonic Healthcare (SKHHY) | Australia | $8.046B | 0.00 |
| Avantor (AVTR) | United States | $7.548B | 11.53 |
| HealthEquity (HQY) | United States | $7.439B | 27.82 |
| BrightSpring Health Services (BTSG) | United States | $7.302B | 43.54 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.580B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $5.940B | 39.00 |
| PACS (PACS) | United States | $5.544B | 33.71 |
| Sotera Health (SHC) | United States | $5.199B | 25.07 |
| Alignment Healthcare (ALHC) | United States | $4.532B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.862B | 50.26 |
| Concentras Parent (CON) | United States | $2.839B | 17.72 |
| Organon (OGN) | United States | $2.132B | 2.25 |
| Progyny (PGNY) | United States | $2.087B | 41.03 |
| Establishment Labs Holdings (ESTA) | United States | $2.070B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.914B | 24.67 |
| Pediatrix Medical (MD) | United States | $1.841B | 10.99 |
| Ardent Health (ARDT) | United States | $1.230B | 4.01 |
| Nutex Health (NUTX) | United States | $1.140B | 8.72 |
| CareDx (CDNA) | United States | $1.050B | 17.16 |
| Teladoc Health (TDOC) | United States | $0.953B | 0.00 |
| Omada Health (OMDA) | United States | $0.861B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.774B | 12.67 |
| InnovAge Holding (INNV) | United States | $0.773B | 0.00 |
| Embecta (EMBC) | United States | $0.648B | 3.68 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.635B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.616B | 0.00 |
| Enhabit (EHAB) | United States | $0.545B | 24.48 |
| SBC Medicals (SBC) | United States | $0.505B | 9.28 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.482B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.408B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.356B | 5.73 |
| Agilon Health (AGL) | United States | $0.343B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.294B | 0.00 |
| So-Young (SY) | China | $0.284B | 0.00 |
| Oncology Institute (TOI) | United States | $0.264B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.158B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.107B | 0.00 |
| Biodesix (BDSX) | United States | $0.082B | 0.00 |
| DocGo (DCGO) | United States | $0.076B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.071B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.042B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Pomdoctor - (POM) | China | $0.025B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.03 |
| OSR Holdings (OSRH) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.014B | 0.00 |
| Lifeward (LFWD) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |